Damir Vrabac is the Co-Founder & COO of Valar Labs, an AI startup that analyzes cancer tissue samples and predicts which type of cancer treatment (surgery, radiation, chemotherapy, etc.) would be most successful for each individual cancer patient. Until now, this has been a very difficult thing for oncologists to predict. This incredible application of AI has the potential to have a life-saving impact on the lives of so many people. The Valar Labs founding team is out of Stanford. Their seed round was led by the venture capital firm Andreessen Horowitz (a16z). Other keywords: Medtech / healthtech / healthcare / digital pathology / medicine / future of medicine.

🎥 Watch the video version of this episode on the Next Unicorn YouTube channel: https://youtu.be/GW99Xn1Zx_s?si=bLS_vmT3SOycMdCw

Follow Damir Vrabac:
👥 LinkedIn: https://www.linkedin.com/in/dvrabac/
🐦 X: https://twitter.com/dvrabac
💻 Valar Labs: https://www.valarlabs.com/

Follow Sasha Earnheart-Gold
👥 LinkedIn: https://www.linkedin.com/in/sashaearnheart-gold/
🐦 X: https://twitter.com/EarnheartGold
🎥 Next Unicorn YouTube channel: https://www.youtube.com/@nextunicorn
📬 Subscribe to the Next Unicorn email newsletter on Substack: https://nextunicorn.substack.com
💻 Next Unicorn podcast website: https://www.nextunicornpodcast.com/
Resources mentioned in this episode:

🎥 Watch the full episode video version on YouTube: https://youtu.be/GW99Xn1Zx_s

Credits:
Video/audio editor and engineer – Oleksii Kyrkach